Akèy › BPCO › North Carolina › Winston-Salem
Etid klinik pou BPCO nan Winston-Salem, NC
9 etid pou BPCO ap chèche patisipan nan sit nan ak bò kote Winston-Salem (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Ap rekriteFaz 3
- Research Site, Winston-Salem
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Ap rekriteFaz 3
- All-Trials Clinical Research- Site Number : 8400008, Winston-Salem
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Ap rekriteFaz 3
- Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400048, Winston-Salem
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Ap rekriteFaz 4
- Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400004, Winston-Salem
Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
Ap rekriteFaz 4
- Southeastern Research Center, Winston-Salem
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Ap rekriteFaz 3
- Research Site, Winston-Salem
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Ap rekriteFaz 2/3
- Salem Chest Specialists, Winston-Salem
- Southeastern Research Center, Winston-Salem
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Ap rekriteFaz 3
- GSK Investigational Site, Winston-Salem
SPIROMICS Study of Early COPD Progression (SOURCE)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Wake Forest, Winston-Salem
Etid BPCO nan lòt vil
- Philadelphia, PA23 etid
- Miami, FL18 etid
- Birmingham, AL17 etid
- Boston, MA17 etid
- Houston, TX15 etid
- Orlando, FL15 etid
- Baltimore, MD14 etid
- Chicago, IL14 etid
- Dallas, TX12 etid
- Pittsburgh, PA12 etid
- New York City, NY11 etid
- Ann Arbor, MI10 etid
Lòt etid nan Winston-Salem
- Kansè (tout kalite)19 etid
- Leksemi mieloïd egi18 etid
- Kansè nan tete14 etid
- Myelom Miltip14 etid
- Maladi kadyovaskilè14 etid
- Kansè Poumon ki pa ti selil12 etid
- Kansè ovè10 etid
- Dyabèt Tip 29 etid
- Sendwòm myelodisplastik9 etid
- Gliyoblastòm8 etid
- Kansè poumon8 etid
- Lukemi lenfositè kwonik8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.